Erlotinib Has Moderate Single-agent Activity in...

Urology 2009 Vol. 74; Iss. 3

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

Chadi Nabhan, Timothy M. Lestingi, Angel Galvez, Kathy Tolzien, Susan K. Kelby, Dean Tsarwhas, Steven Newman, Jacob D. Bitran
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
74
Year:
2009
Language:
english
DOI:
10.1016/j.urology.2009.05.016
File:
PDF, 328 KB
english, 2009
Conversion to is in progress
Conversion to is failed